Immunomedics submits LeukoScan to FDA
Immunomedics of Morris Plains, NJ, has submitted a biologies licenseapplication to the Food and Drug Administration for approval ofLeukoScan, a technetium-99m-labeled monoclonal antibody-basedagent for imaging bone infection. LeukoScan received a
Immunomedics of Morris Plains, NJ, has submitted a biologies license
application to the Food and Drug Administration for approval of
LeukoScan, a technetium-99m-labeled monoclonal antibody-based
agent for imaging bone infection. LeukoScan received a positive
recommendation from Europe's Committee for Proprietary Medicinal
Products in October (SCAN 10/23/96).